Details for New Drug Application (NDA): 020887
✉ Email this page to a colleague
The generic ingredient in ACUTECT is technetium tc-99m apcitide. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m apcitide profile page.
Summary for 020887
Tradename: | ACUTECT |
Applicant: | Cis Bio Intl Sa |
Ingredient: | technetium tc-99m apcitide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | N/A | ||||
Approval Date: | Sep 14, 1998 | TE: | RLD: | No |
Expired US Patents for NDA 020887
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | ⤷ Subscribe | ⤷ Subscribe |
Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | ⤷ Subscribe | ⤷ Subscribe |
Cis Bio Intl Sa | ACUTECT | technetium tc-99m apcitide | INJECTABLE;INJECTION | 020887-001 | Sep 14, 1998 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription